Safety and clinical efficacy of golimumab in the treatment of arthritides
Ismail Simsek, Yusuf YaziciNew York University School of Medicine, NYU Hospital for Joint Diseases, New York, USAAbstract: Golimumab is a human anti-tumor necrosis factor (TNF)-alpha monoclonal antibody that was recently approved for the treatment of patients with rheumatoid arthritis, psoriatic art...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2010-09-01
|
Series: | Drug, Healthcare and Patient Safety |
Online Access: | http://www.dovepress.com/safety-and-clinical-efficacy-of-golimumab-in-the-treatment-of-arthriti-a5373 |